Table 1 Association of TC2N expression with lung cancer clinicopathological characteristics
Variable | Category | Relative TC2N expression | P | ||
|---|---|---|---|---|---|
High (n = 143) | Medium (n = 100) | Low (n = 29) |  | ||
Age (years) | <60 | 45 | 40 | 12 | 0.310 |
|  | ≥60 | 97 | 59 | 17 | |
Histological type | ADC | 90 | 73 | 19 | 0.257 |
| Â | SCC | 53 | 27 | 10 | |
Clinical stage | I | 35 | 30 | 14 | 0.006 |
(AJCC) | II | 31 | 39 | 5 | |
| Â | III | 53 | 22 | 7 | |
| Â | IV | 1 | 1 | 1 | |
Gender | Male | 98 | 63 | 22 | 0.386 |
| Â | Female | 45 | 37 | 7 | |
Histological grade | 1 | 2 | 13 | 7 | <0.001 |
| Â | 2 | 88 | 78 | 21 | |
|  | 3  | 53 | 9 | 1 | |
Tumor size | ≤3cm | 43 | 34 | 8 | 0.776 |
|  | >3 cm | 89 | 62 | 20 | |
Lymph node status | Negative | 58 | 44 | 19 | 0.067 |
| Â | Positive | 68 | 48 | 8 | |
